## 1. EXECUTIVE SUMMARY
Premium+ Subscribers will get these for all stocks they list in their 10-stock portfolio that we will track for them on Occam's Investing
Intel beat its own Q4 guidance on revenue, gross margin, and EPS, but the beat is tempered by a critical admission: supply constraints prevented Intel from fully capturing demand, meaning the upside was artificially capped — not a clean beat. Lip-Bu Tan is executing a credible turnaround narrative with genuine operational milestones (18A shipping, Series 3 launched, organizational restructuring), but the company remains on a multi-year recovery arc with no near-term inflection point clearly defined. The transcript is heavy on roadmap language and light on hard financial data, which is itself a signal worth noting.